GlucoTrack, Inc. (GCTK)
0.4032
-0.20
(-32.67%)
USD |
NASDAQ |
Oct 23, 16:00
0.42
+0.02
(+4.17%)
After-Hours: 20:00
GlucoTrack Max Drawdown (5Y) : 100.00% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 100.00% |
| August 31, 2026 | 100.00% |
| July 31, 2026 | 100.00% |
| June 30, 2026 | 100.00% |
| May 31, 2026 | 100.00% |
| April 30, 2026 | 100.00% |
| March 31, 2026 | 100.00% |
| February 28, 2026 | 100.00% |
| January 31, 2026 | 100.00% |
| December 31, 2025 | 99.99% |
| November 30, 2025 | 99.99% |
| October 31, 2025 | 99.99% |
| September 30, 2025 | 99.99% |
| August 31, 2025 | 99.99% |
| July 31, 2025 | 99.99% |
| June 30, 2025 | 99.99% |
| May 31, 2025 | 99.98% |
| April 30, 2025 | 99.98% |
| March 31, 2025 | 99.98% |
| February 28, 2025 | 99.96% |
| January 31, 2025 | 99.84% |
| December 31, 2024 | 99.49% |
| November 30, 2024 | 99.49% |
| October 31, 2024 | 98.97% |
| September 30, 2024 | 98.97% |
| Date | Value |
|---|---|
| August 31, 2024 | 98.97% |
| July 31, 2024 | 98.97% |
| June 30, 2024 | 98.97% |
| May 31, 2024 | 98.97% |
| April 30, 2024 | 98.97% |
| March 31, 2024 | 98.97% |
| February 29, 2024 | 98.97% |
| January 31, 2024 | 98.97% |
| December 31, 2023 | 98.97% |
| November 30, 2023 | 98.97% |
| October 31, 2023 | 98.97% |
| September 30, 2023 | 98.97% |
| August 31, 2023 | 98.97% |
| July 31, 2023 | 98.97% |
| June 30, 2023 | 98.97% |
| May 31, 2023 | 98.97% |
| April 30, 2023 | 98.97% |
| March 31, 2023 | 98.88% |
| February 28, 2023 | 98.88% |
| January 31, 2023 | 98.88% |
| December 31, 2022 | 98.88% |
| November 30, 2022 | 98.88% |
| October 31, 2022 | 98.88% |
| September 30, 2022 | 98.88% |
| August 31, 2022 | 98.88% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Nuwellis, Inc. | 100.0% |
| Abbott Laboratories | 39.63% |
| AngioDynamics, Inc. | 82.98% |
| Alphatec Holdings, Inc. | 73.51% |
| AtriCure, Inc. | 77.21% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -103.12 |
| Beta (5Y) | 0.7266 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 144.8% |
| Historical Sharpe Ratio (5Y) | -0.6622 |
| Historical Sortino (5Y) | -1.324 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 66.17% |